Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study
Top Cited Papers
- 20 July 2017
- journal article
- research article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 67 (5), 918-924
- https://doi.org/10.1016/j.jhep.2017.07.012
Abstract
No abstract availableKeywords
Funding Information
- Gilead Sciences
This publication has 23 references indexed in Scilit:
- Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up studyThe Lancet, 2012
- Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With AdefovirGastroenterology, 2012
- Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patientsHepatology International, 2012
- Safety of long-term nucleos(t)ide treatment in chronic hepatitis BExpert Opinion on Drug Safety, 2012
- Durability of viral response after off-treatment in HBeAg positive chronic hepatitis BWorld Journal of Gastroenterology, 2012
- Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or CHepatology, 2011
- Hepatitis B surface antigen: association with sustained response to peginterferon alfa-2a in hepatitis B e antigen-positive patientsHepatology International, 2011
- Chronic hepatitis B: Update 2009Hepatology, 2009
- Chronic hepatitis BHepatology, 2007
- Sustained response after a 2‐year course of lamivudine treatment of hepatitis B e antigen‐negative chronic hepatitis BJournal of Viral Hepatitis, 2004